Immunohistochemical Evaluation of Schlafen 11 (SLFN11) Expression in Cancer in the Search of Biomarker-Informed Treatment Targets: A Study of 127 Entities Represented by 6658 Tumors.

Autor: Kaczorowski M; Laboratory of Pathology, National Cancer Institute, Bethesda, MD.; Department of Clinical and Experimental Pathology, Wroclaw Medical University, Wrocław, Poland., Ylaya K; Laboratory of Pathology, National Cancer Institute, Bethesda, MD., Chłopek M; Laboratory of Pathology, National Cancer Institute, Bethesda, MD., Taniyama D; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Pommier Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Lasota J; Laboratory of Pathology, National Cancer Institute, Bethesda, MD., Miettinen M; Laboratory of Pathology, National Cancer Institute, Bethesda, MD.

Publikováno v: The American journal of surgical pathology [Am J Surg Pathol] 2024 Aug 26. Date of Electronic Publication: 2024 Aug 26.

Use of SATB2 and CDX2 Immunohistochemistry to Characterize and Diagnose Colorectal Cancer.

Autor: Kato S; Department of Internal Medicine, Division of Gastroenterology., Koshino A; Department of Internal Medicine, Division of Gastroenterology., Lasota J; Laboratory of Pathology, National Cancer Institute, Bethesda, MD., Komura M; Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences., Wang C; Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences., Ebi M; Department of Internal Medicine, Division of Gastroenterology., Ogasawara N; Department of Internal Medicine, Division of Gastroenterology., Kojima K; Departments of Gynecology., Tsuzuki T; Surgical Pathology., Kasai K; Department of Pathology, Aichi Medical University School of Medicine, Nagakute, Japan., Takahashi S; Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences., Miettinen M; Laboratory of Pathology, National Cancer Institute, Bethesda, MD., Kasugai K; Department of Internal Medicine, Division of Gastroenterology., Inaguma S; Department of Pathology, Aichi Medical University School of Medicine, Nagakute, Japan.; Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences.; Pathology, Nagoya City University East Medical Center, Nagoya, Japan.

Publikováno v: Applied immunohistochemistry & molecular morphology : AIMM [Appl Immunohistochem Mol Morphol] 2024 Sep 01; Vol. 32 (8), pp. 362-370. Date of Electronic Publication: 2024 Jul 30.

Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis type 1 (NF1).

Autor: Lucas CG; Department of Pathology, Johns Hopkins University, Baltimore, MD.; Department of Oncology, Johns Hopkins University, Baltimore, MD.; Department of Neurosurgery, Johns Hopkins University, Baltimore, MD., Gross AM; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Romo CG; Department of Oncology, Johns Hopkins University, Baltimore, MD.; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Dehner CA; Department of Pathology, Indiana University, Indianapolis, Indiana., Lazar AJ; Department of Pathology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Miettinen M; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Pekmezci M; Department of Pathology, University of California San Francisco, San Francisco, CA.; Department of Ophthalmology, University of California San Francisco, San Francisco, CA., Quezado M; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Rodriguez FJ; Department of Pathology, University of California Los Angeles, Los Angeles, CA., Stemmer-Rachamimov A; Department of Pathology, Massachusetts General Hospital, Boston, MA., Viskochil D; Department of Pediatrics, University of Utah, Salt Lake City, UT., Perry A; Department of Pathology, University of California San Francisco, San Francisco, CA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA.

Publikováno v: Neuro-oncology [Neuro Oncol] 2024 Nov 06. Date of Electronic Publication: 2024 Nov 06.

Miettinen M, Lasota J: Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438: 1-12

Autor: Miettinen, Markku, Lasota, Jerzy

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal (GI) tract. They are defined here as KIT (CD117, stem cell factor receptor)-positive mesenchymal spindle cell or epithelioid neoplasms primary in t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2659::0095f9339bf1f54b527fec2bf20c3cfc
https://zenodo.org/record/1232705

Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities.

Autor: Desai P; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Department of Medical Oncology, Fox Chase Cancer Center, Temple University Hospital and Lewis Katz School of Medicine, Philadelphia, PA, USA., Takahashi N; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Kumar R; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Nichols S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Malin J; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Hunt A; Women's Health Integrated Research Center, Inova Health System, Falls Church, VA, USA., Schultz C; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Cao Y; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Tillo D; CCR Collaborative Bioinformatics, Resource, Office of Science and Technology Resources, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Nousome D; CCR Collaborative Bioinformatics, Resource, Office of Science and Technology Resources, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Chauhan L; Center for Biosystems Science and Engineering, Indian Institute of Science, Bangalore, India., Sciuto L; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Jordan K; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Rajapakse V; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Tandon M; CCR Collaborative Bioinformatics, Resource, Office of Science and Technology Resources, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lissa D; Laboratory of Human Carcinogenesis, Center for Cancer Research National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Zhang Y; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kumar S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Pongor L; HCEMM Cancer Genomics and Epigenetics Research Group, Szeged, Hungary., Singh A; Center for Biosystems Science and Engineering, Indian Institute of Science, Bangalore, India., Schroder B; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Sharma AK; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Chang T; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Vilimas R; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Pinkiert D; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Graham C; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Butcher D; Molecular Histopathology Laboratory, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Warner A; Molecular Histopathology Laboratory, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Sebastian R; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Mahon M; Pain and Palliative care services, National Institutes of Health Clinical Center, Bethesda, MD, USA., Baker K; Pain and Palliative care services, National Institutes of Health Clinical Center, Bethesda, MD, USA., Cheng J; Pain and Palliative care services, National Institutes of Health Clinical Center, Bethesda, MD, USA., Berger A; Pain and Palliative care services, National Institutes of Health Clinical Center, Bethesda, MD, USA., Lake R; Laboratory of Genitourinary cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Abel M; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Krishnamurthy M; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Chrisafis G; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Fitzgerald P; CCR Collaborative Bioinformatics, Resource, Office of Science and Technology Resources, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Nirula M; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Goyal S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Atkinson D; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Bateman NW; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD, USA., Abulez T; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD, USA., Nair G; National Institute of Neurological Disorders and Stroke, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Apolo A; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Guha U; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Karim B; Molecular Histopathology Laboratory, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., El Meskini R; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Ohler ZW; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Jolly MK; Center for Biosystems Science and Engineering, Indian Institute of Science, Bangalore, India., Schaffer A; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Ruppin E; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kleiner D; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Miettinen M; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Brown GT; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Hewitt S; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Conrads T; Women's Health Integrated Research Center, Inova Health System, Falls Church, VA, USA., Thomas A; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: anish.thomas@nih.gov.

Publikováno v: Cell reports. Medicine [Cell Rep Med] 2024 Jun 18; Vol. 5 (6), pp. 101610.